FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

789696002: Antitubercular therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3792983013 Antitubercular therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3792984019 Antitubercular therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antitubercular therapeutic role Is a Antimycobacterial therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing rifamycin (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only rifamycin (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing rifamycin in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only rifamycin in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for injection Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely isoniazid 10 milligram/1 milliliter conventional release oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 20 milligram/1 milliliter conventional release oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Aminosalicylic acid Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Bedaquiline Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Capreomycin Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing isoniazid Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing pretomanid (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only pretomanid (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing pretomanid in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only pretomanid in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing para-aminosalicylate (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only para-aminosalicylate (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing para-aminosalicylate in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only para-aminosalicylate in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing amoxicillin and omeprazole and rifabutin (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only amoxicillin and omeprazole and rifabutin (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing amoxicillin and omeprazole and rifabutin in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only amoxicillin and omeprazole and rifabutin in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pyrazinamide 400 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bedaquiline (as bedaquiline fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely delamanid 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cycloserine 125 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ethionamide 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ethionamide 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ethambutol 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely para-aminosalicylic acid 4 gram/1 sachet gastro-resistant oral granules (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely para-aminosalicylic acid 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pyrazinamide 150 milligram/1 each tablet for conventional release oral suspension (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely rifampicin 600 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 300mg powder and solvent for solution for injection vials Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 170mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 75mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Bedaquiline 100mg tablets Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 100mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 250mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 100mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 27mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 1.4g/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 1.25g/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Aminosalicylic acid gastro-resistant granules 4g sachets sugar free Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 650mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 490mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 600mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 80mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 700mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 30.5mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 150mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 250mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 625mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 125mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 500mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 50mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Delamanid 50mg tablets Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 90mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 675mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 400mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 125mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 480mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 1.4g/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 200mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 425mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 210mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 312.5mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 105mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 120mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 420mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 700mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 430mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 300mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 50mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 200mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 400mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 850mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 91mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 100mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 600mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 100mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 480mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 150mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 450mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Pyrazinamide 300mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Ethambutol 250mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 30.5mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 600mg powder and solvent for solution for infusion vials Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifampicin 300mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Rifabutin 60mg/5ml oral suspension Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier
Isoniazid 119mg/5ml oral solution Plays role True Antitubercular therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 4 Next End

This concept is not in any reference sets

Back to Start